Pimavanserin Snag: FDA Rejects Acadia’s Dementia Psychosis Drug
Acadia Pharmaceuticals said today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration regarding its supplemental New…
Acadia Pharmaceuticals said today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration regarding its supplemental New…
The ocean deep holds untapped potential when it comes to new therapies that could treat diseases like cancer and Alzheimer’s. But climate change and…
What can the novel coronavirus pandemic teach us about dementia? How are rural communities grappling with the public health toll of cognitive decline? How…
People are always looking for an accessible, prescription-free aid for pain, insomnia, anxiety and other day-to-day irritations. In recent years, CBD has emerged as…
The article is part II of a Being Patient series about the financial burdens of dementia. Check out part I and part III for…
A new study indicates that the brain-boosting benefits of psychological resilience — including overcoming conditions like persistent loneliness — might offset harm and ultimately…
In 2013, Amylyx Pharmaceuticals co-founders Justin Klee and Josh Cohen, undergraduate students at Brown University at the time, hypothesized that targeting two dysfunctional pathways…
Stanley Tucci and Colin Firth, two Hollywood greats, play a couple grappling with a dementia diagnosis in new romantic drama Supernova. Caring for someone…
Concussions are one of the most common injuries in football, and medical experts are increasingly concerned that repeated head traumas could lead to heightened…
Day-to-day activities at home could potentially turn into dangerous situations for people living with dementia. Incidents such as leaving the stove on when cooking…
Developing a new drug start to finish can take years — even decades — and cost billions. But, there’s a shortcut: repurposing old drugs…
What if the reason we can’t seem to crack the code on how to prevent, treat, or even fully understand Alzheimer’s disease is that……
This weekend, Eli Lilly and Company presented detailed results of its phase 2 TRAILBLAZER-ALZ trial, showing that its investigational drug donanemab — monoclonal antibody…
(UPDATED Sat. March 13, 2021) In January, excitement rippled through the Alzheimer’s community with drugmaker Eli Lilly and Company’s announcement that their experimental drug…
People don’t often plan for potential dementia diagnosis, but given the financial impacts of dementia care and the prevalence of the disease, experts say it…